This is a Phase 1/2A study designed to evaluate the safety and tolerability of increased repeated doses of LYC-55716 in subjects with locally advanced or metastatic solid tumors.
Principal Investigator
Joseph Mccormick
Juliana Lopez
9565886655
lopezj21@uthscsa.edu